Indications
This medicinal product is for diagnostic use only. LeukoScan is indicated for diagnostic imaging for determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers. LeukoScan has not been employed to diagnose osteomyelitis in patients with sickle cell anaemia.
Composition
- Active substance
- sulesomab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- LeukoScan
- Active substance
- sulesomab
- ATC code
- VO4D
- Group
- Various
- Therapeutic area
- Osteomyelitis, Radionuclide Imaging
- Marketing authorisation holder
- Immunomedics GmbH